Premium
Oxidation Products Arising from the Action of Monoamine Oxidase B on 1‐Methyl‐4‐Benzyl‐1,2,3,6‐Tetrahydropyridine, a Nonneurotoxic Analogue of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine
Author(s) -
Sablin Sergey O.,
Krueger Matthew J.,
Bachurin Sergey O.,
Solyakov Lev S.,
Efange Simon M. N.,
Singer Thomas P.
Publication year - 1994
Publication title -
journal of neurochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.75
H-Index - 229
eISSN - 1471-4159
pISSN - 0022-3042
DOI - 10.1046/j.1471-4159.1994.62052012.x
Subject(s) - chemistry , monoamine oxidase , medicinal chemistry , action (physics) , stereochemistry , organic chemistry , enzyme , physics , quantum mechanics
1‐Methyl‐4‐benzyl‐1,2,3,6‐tetrahydropyridine (MBzTP), an analogue of the neurotoxin 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine, despite its rapid oxidation by monoamine oxidase B (MAOB), is not neurotoxic. The pyridinium expected to arise from the four‐electron oxidation of MBzTP inhibits mitochondrial respiration and the oxidation of NADH in inner membranes and is only moderately less inhibitory than 1‐methyl‐4‐phenylpyridinium. It is also a competitive inhibitor of dopamine uptake by the dopamine transporter and hence likely to be taken up into neurons, despite its relatively high K 1 value ( K 1 = 21 μ M ). Incubation of MBzTP with purified MAO B yields first the dihydropyridinium form, then a mixture of the pyridinium form and another unidentified product, in proportions that depend on the concentrations of MAO B and oxygen. At low MAO B concentration and moderate oxygen concentration, nonenzymatic formation, of the unidentified product predominates. The lack of neurotoxicity of MBzTP appears to be due to the oxidative destruction of the dihydropyridine and consequent failure of accumulation of 1‐methyl‐4‐behzylpyridinium.